The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
PaxLyte
leucovorin, folic acid, levomefolate magnesium, ferrous cysteine glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium, phosphatidyl serine, pyridoxal 5-phosphate, flavin adenine dinucleotide, nadh, cobamamide, cocarboxylase (thiamine pyrophosphate), magnesium ascorbate, zinc ascorbate, magnesium l-threonate and betaine capsule · LEUCOVORIN 2.5 mg/1; FOLIC ACID 1 mg/1; LEVOMEFOLATE MAGNESIUM 7 mg/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; PHOSPHATIDYL SERINE 12 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; NADH 25 ug/1; COBAMAMIDE 50 ug/1; COCARBOXYLASE 25 ug/1; MAGNESIUM ASCORBATE 24 mg/1; ZINC ASCORBATE 1 mg/1; MAGNESIUM L-THREONATE 1 mg/1; BETAINE 500 mg/1; CITRIC ACID MONOHYDRATE 1.83 mg/1; SODIUM CITRATE 1.83 mg/1 · Capsule · Oral · Jaymac Pharmaceuticals
NDC 64661-0217-30 · 30 CAPSULE in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of leucovorin, folic acid, levomefolate magnesium, ferrous cysteine glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium, phosphatidyl serine, pyridoxal 5-phosphate, flavin adenine dinucleotide, nadh, cobamamide, cocarboxylase (thiamine pyrophosphate), magnesium ascorbate, zinc ascorbate, magnesium l-threonate and betaine capsule (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Jaymac Pharmaceuticals | LEUCOVORIN 2.5 mg/1; FOLIC ACID 1 mg/1; LEVOMEFOLATE MAGNESIUM 7 mg/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; PHOSPHATIDYL SERINE 12 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; NADH 25 ug/1; COBAMAMIDE 50 ug/1; COCARBOXYLASE 25 ug/1; MAGNESIUM ASCORBATE 24 mg/1; ZINC ASCORBATE 1 mg/1; MAGNESIUM L-THREONATE 1 mg/1; BETAINE 500 mg/1; CITRIC ACID MONOHYDRATE 1.83 mg/1; SODIUM CITRATE 1.83 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Jaymac Pharmaceuticals | LEUCOVORIN 6.4 mg/1; FOLIC ACID 800 ug/1; LEVOMEFOLATE MAGNESIUM 500 mg/1; FERROUS CYSTEINE GLYCINATE 1.83 mg/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 50 ug/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 25 ug/1; PHOSPHATIDYL SERINE 13.6 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 1 mg/1; NADH 2.5 mg/1; COBAMAMIDE 7 mg/1; COCARBOXYLASE 24 mg/1; MAGNESIUM ASCORBATE 1 mg/1; ZINC ASCORBATE 25 ug/1; MAGNESIUM L-THREONATE 12 mg/1; BETAINE 25 ug/1; CITRIC ACID MONOHYDRATE 1.83 mg/1; SODIUM CITRATE 1 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Jaymac Pharmaceuticals | 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; BETAINE 500 mg/1; CITRIC ACID MONOHYDRATE 1.83 mg/1; COBAMAMIDE 50 ug/1; COCARBOXYLASE 25 ug/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; FOLIC ACID 1 mg/1; LEUCOVORIN 2.5 mg/1; LEVOMEFOLATE MAGNESIUM 7 mg/1; MAGNESIUM ASCORBATE 24 mg/1; MAGNESIUM L-THREONATE 1 mg/1; NADH 25 ug/1; PHOSPHATIDYL SERINE 12 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; SODIUM CITRATE 1.83 mg/1; ZINC ASCORBATE 1 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "PaxLyte — NDC 64661-0217-30," retrieved September 3, 2026, https://drugdashboards.com/drug/64661021730.
Free to cite with attribution — see how the data is put together.